Report Categories
View AllRecent Articles
View All
NKTR Nektar Therapeutics posts narrower Q4 2025 loss than estimates shares gain 167 percent in todays session
The valuation case for Processa Pharmaceuticals PCSA that is hard to ignore 436 20260508
Why Indonesia INDO might surprise investors this quarter Trend Strengthens 20260508
Baidu Inc BIDU Announces 2026 Annual General Meeting Date Publishes 2025 FullYear Regulatory Filings